Pallikkuth, Suresh <br/><br/>
Interleukin-21 administration to rhesus macaques chronically infected with simian immunodeficiency virus increases cytotoxic effector molecules in T cells and NK cells and enhances B cell function without increasing immune activation or viral replication.  [electronic resource] 

 -  Vaccine  Nov 2011 
 - 9229-38 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2011.09.118  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Viral--blood<br/>B-Lymphocytes--immunology<br/>CD4-Positive T-Lymphocytes--immunology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cell Proliferation<br/>Granzymes--immunology<br/>Immunologic Memory<br/>Interferon-gamma--immunology<br/>Interleukins--pharmacology<br/>Killer Cells, Natural--immunology<br/>Lymphocyte Activation<br/>Lysosomal-Associated Membrane Protein 1--metabolism<br/>Macaca mulatta--immunology<br/>Perforin--immunology<br/>Pilot Projects<br/>RNA, Viral--blood<br/>Simian Acquired Immunodeficiency Syndrome--drug therapy<br/>Simian Immunodeficiency Virus--immunology<br/>Tumor Necrosis Factor Receptor Superfamily, Member 7--metabolism<br/>Viral Load<br/>Interleukin-21